RBM4 and esophageal squamous cell carcinoma: These findings provide novel mechanistic insights into ESCC progression depending on glutamine metabolism and uncover RBM4 as a potential biomarker and causative factor for targeting glutamine addiction in the diagnosis and treatment of ESCC.